APO Research
Talk to an analyst

APO RESEARCH · REPORT

Spinal and Bulbar Muscular Atrophy Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Spinal and Bulbar Muscular Atrophy Treatment Industry Growth and Trends Forecast to 2032

19 December 202588 pages

Choose your research edition.

Industry ResearchSpinal and Bulbar Muscular Atrophy Treatment Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Spinal and Bulbar Muscular Atrophy Treatment Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Spinal and Bulbar Muscular Atrophy Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spinal and Bulbar Muscular Atrophy Treatment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Spinal and Bulbar Muscular Atrophy Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

According to APO Research, the global Spinal and Bulbar Muscular Atrophy Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Spinal and Bulbar Muscular Atrophy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Spinal and Bulbar Muscular Atrophy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Spinal and Bulbar Muscular Atrophy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Spinal and Bulbar Muscular Atrophy Treatment market include Sanofi, Johnson & Johnson, Pfizer, GlaxoSmithKline, AbbVie, Century Pharmaceuticals, Boehringer Ingelheim International and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Spinal and Bulbar Muscular Atrophy Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Spinal and Bulbar Muscular Atrophy Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Spinal and Bulbar Muscular Atrophy Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Spinal and Bulbar Muscular Atrophy Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Spinal and Bulbar Muscular Atrophy Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Spinal and Bulbar Muscular Atrophy Treatment Market by Company

Sanofi

Johnson & Johnson

Pfizer

GlaxoSmithKline

AbbVie

Century Pharmaceuticals

Boehringer Ingelheim International

Astellas Pharma

Spinal and Bulbar Muscular Atrophy Treatment Segment by Type

5α-Reductase Inhibitors

Gonadotropin-releasing Hormone Agonists

Spinal and Bulbar Muscular Atrophy Treatment Segment by Application

Hospitals

Ambulatory Surgical Centers

Orthopedic Clinics

Spinal and Bulbar Muscular Atrophy Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spinal and Bulbar Muscular Atrophy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spinal and Bulbar Muscular Atrophy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spinal and Bulbar Muscular Atrophy Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Spinal and Bulbar Muscular Atrophy Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region (2021-2026) Table 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region (2027-2032) Table 6. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Type (2021-2026) Table 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2021-2026) Table 24. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Spinal and Bulbar Muscular Atrophy Treatment Industry Trends Table 37. Spinal and Bulbar Muscular Atrophy Treatment Industry Drivers Table 38. Spinal and Bulbar Muscular Atrophy Treatment Industry Opportunities and Challenges Table 39. Spinal and Bulbar Muscular Atrophy Treatment Industry Restraints Table 40. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Spinal and Bulbar Muscular Atrophy Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Spinal and Bulbar Muscular Atrophy Treatment Key Company Headquarters & Area Served Table 44. Global Spinal and Bulbar Muscular Atrophy Treatment Company, Product Type & Application Table 45. Global Spinal and Bulbar Muscular Atrophy Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Spinal and Bulbar Muscular Atrophy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Spinal and Bulbar Muscular Atrophy Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio Table 52. Sanofi Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Spinal and Bulbar Muscular Atrophy Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Pfizer Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio Table 62. Pfizer Recent Development Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. AbbVie Company Information Table 69. AbbVie Business Overview Table 70. AbbVie Spinal and Bulbar Muscular Atrophy Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AbbVie Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio Table 72. AbbVie Recent Development Table 73. Century Pharmaceuticals Company Information Table 74. Century Pharmaceuticals Business Overview Table 75. Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio Table 77. Century Pharmaceuticals Recent Development Table 78. Boehringer Ingelheim International Company Information Table 79. Boehringer Ingelheim International Business Overview Table 80. Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio Table 82. Boehringer Ingelheim International Recent Development Table 83. Astellas Pharma Company Information Table 84. Astellas Pharma Business Overview Table 85. Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio Table 87. Astellas Pharma Recent Development Table 88. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2026) Table 91. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share Forecast by Country (2027-2032) Table 93. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026) & (US$ Million) Table 95. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2026) Table 96. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share Forecast by Country (2027-2032) Table 98. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026) & (US$ Million) Table 100. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2026) Table 101. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share Forecast by Country (2027-2032) Table 103. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2026) Table 106. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share Forecast by Country (2027-2032) Table 108. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2026) Table 111. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share Forecast by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Spinal and Bulbar Muscular Atrophy Treatment Product Image Figure 3. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region (2021-2032) Figure 7. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. 5α-Reductase Inhibitors Image Figure 13. Global 5α-Reductase Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Gonadotropin-releasing Hormone Agonists Image Figure 15. Global Gonadotropin-releasing Hormone Agonists Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type 2025 VS 2032 Figure 18. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Type (2021-2032) Figure 19. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Type (2021-2032) Figure 21. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Type (2021-2032) Figure 23. Hospitals Image Figure 24. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Ambulatory Surgical Centers Image Figure 26. Global Ambulatory Surgical Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Orthopedic Clinics Image Figure 28. Global Orthopedic Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application 2025 VS 2032 Figure 31. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2021-2032) Figure 32. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2021-2032) Figure 34. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Spinal and Bulbar Muscular Atrophy Treatment Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2032) Figure 41. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2032) Figure 44. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2032) Figure 47. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2032) Figure 50. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • 5α-Reductase Inhibitors
  • Gonadotropin-releasing Hormone Agonists
Applications
  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopedic Clinics
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Pfizer
  • GlaxoSmithKline
  • AbbVie
  • Century Pharmaceuticals
  • Boehringer Ingelheim International
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Spinal and Bulbar Muscular Atrophy Treatment Market Size (2021-2032)
  8. 1.5.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (2021-2032)
2 Spinal and Bulbar Muscular Atrophy Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 5α-Reductase Inhibitors
  3. 2.1.2 Gonadotropin-releasing Hormone Agonists
  4. 2.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
  5. 2.2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions
  9. 2.3.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Type (2021-2026)
3 Spinal and Bulbar Muscular Atrophy Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Ambulatory Surgical Centers
  4. 3.1.3 Orthopedic Clinics
  5. 3.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
  6. 3.2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions
  10. 3.3.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Spinal and Bulbar Muscular Atrophy Treatment Industry Trends
  2. 4.2 Spinal and Bulbar Muscular Atrophy Treatment Industry Drivers
  3. 4.3 Spinal and Bulbar Muscular Atrophy Treatment Industry Opportunities and Challenges
  4. 4.4 Spinal and Bulbar Muscular Atrophy Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Spinal and Bulbar Muscular Atrophy Treatment Revenue (2021-2026)
  2. 5.2 Global Spinal and Bulbar Muscular Atrophy Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Spinal and Bulbar Muscular Atrophy Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Spinal and Bulbar Muscular Atrophy Treatment Company, Product Type & Application
  5. 5.5 Global Spinal and Bulbar Muscular Atrophy Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Spinal and Bulbar Muscular Atrophy Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Spinal and Bulbar Muscular Atrophy Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 Century Pharmaceuticals
  32. 6.6.1 Century Pharmaceuticals Company Information
  33. 6.6.2 Century Pharmaceuticals Business Overview
  34. 6.6.3 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio
  36. 6.6.5 Century Pharmaceuticals Recent Developments
  37. 6.7 Boehringer Ingelheim International
  38. 6.7.1 Boehringer Ingelheim International Company Information
  39. 6.7.2 Boehringer Ingelheim International Business Overview
  40. 6.7.3 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio
  42. 6.7.5 Boehringer Ingelheim International Recent Developments
  43. 6.8 Astellas Pharma
  44. 6.8.1 Astellas Pharma Company Information
  45. 6.8.2 Astellas Pharma Business Overview
  46. 6.8.3 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Product Portfolio
  48. 6.8.5 Astellas Pharma Recent Developments
7 North America
  1. 7.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst